sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
4-May-2016 09:45
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 876-900 out of 1224.

<< < 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 > >>

Public Release: 9-Dec-2014
Bayer and DNDi sign agreement to develop an oral treatment for river blindness
Bayer HealthCare and the Drugs for Neglected Diseases initiative have signed an agreement under which Bayer will provide the active ingredient emodepside to support DNDi in its effort to develop a new oral drug to treat river blindness (or onchocerciasis). The world's second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm.

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Public Release: 9-Dec-2014
ACS Nano
Nanotechnology against malaria parasites
Malaria parasites invade human red blood cells; they then disrupt them and infect others. Researchers at the University of Basel and the Swiss Tropical and Public Health Institute have now developed so-called nanomimics of host cell membranes that trick the parasites. This could lead to novel treatment and vaccination strategies in the fight against malaria and other infectious diseases. Their research results have been published in the scientific journal ACS Nano.

Contact: Olivia Poisson
University of Basel

Public Release: 9-Dec-2014
Genome Research
Using genome sequencing to track MRSA in under-resourced hospitals
Whole genome sequencing of MRSA from a hospital in Asia has demonstrated patterns of transmission in a resource-limited setting, where formal screening procedures are not feasible.

Contact: Sarah Collins
University of Cambridge

Public Release: 9-Dec-2014
International Journal of Epidemiology
Experts call for faster mobilization of 'overlooked' survivors to contain Ebola epidemic
In an editorial published online today in the International Journal of Epidemiology, experts from the Departments of Psychiatry and Epidemiology at Columbia University, New York, are calling for survivors of the Ebola epidemic to be mobilised in a bid to hasten containment of the disease.

Contact: Kirsty Doole
Oxford University Press

Public Release: 9-Dec-2014
Genome Research
Genome sequencing traces MRSA spread in high transmission setting
Methicillin-resistant Staphylococcus aureus is a common cause of hospital-acquired infections, with the largest burden of infections occurring in under-resourced hospitals. While genome sequencing has previously been applied in well-resourced clinical settings to track the spread of MRSA, transmission dynamics in settings with limited infection control is unknown. In a study published online today in Genome Research, researchers used genome sequencing to understand the spread of MRSA in a resource-limited hospital with high transmission rates.
Medical Research Council, Wellcome Trust, NIHR Cambridge Biomedical Research Centre

Contact: Peggy Calicchia
Cold Spring Harbor Laboratory

Public Release: 8-Dec-2014
Annals of Global Health
Asbestos: An ongoing challenge to global health
Challenges to global health can evolve from policies and decisions that take years or decades to unfold. An article in the current issue of the Annals of Global Health describes the current state of asbestos use worldwide, a story that began over 100 years ago, and the real and contrived controversies regarding asbestos.

Contact: Eileen Leahy
Elsevier Health Sciences

Public Release: 8-Dec-2014
Each dollar spent on kids' nutrition can yield more than $100 later
There are strong economic incentives for governments to invest in early childhood nutrition, reports a new paper from the University of Waterloo and Cornell University. Published for the Copenhagen Consensus Centre, the paper reveals that every dollar spent on nutrition during the first 1,000 days of a child's life can provide a country up to $166 in future earnings.

Contact: Pamela Smyth
University of Waterloo

Public Release: 8-Dec-2014
Rapid Ebola test is focus of NIH grant to Rutgers scientist
Rutgers researcher David Alland, working with the California biotechnology company Cepheid, has received a grant of nearly $640,000 from the National Institutes of Health to develop a rapid test to diagnose Ebola as well as other viruses that can cause symptoms similar to Ebola. Alland and Cepheid previously used technology similar to the planned Ebola test to develop a rapid test for tuberculosis that is now widely used in impoverished areas of the world.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Rob Forman
Rutgers University

Public Release: 8-Dec-2014
Combining insecticide sprays and bed nets 'no more effective' in cutting malaria
There is no need to spray insecticide on walls for malaria control when people sleep under treated bed nets, according to new research by Durham University and the Medical Research Council's Unit in The Gambia.
Medical Research Council

Contact: Steve Lindsay
Durham University

Public Release: 8-Dec-2014
Nature Cell Biology
A pill for obesity?
Harvard Stem Cell Institute researchers at Harvard and Massachusetts General Hospital have taken what they are describing as 'the first step toward a pill that can replace the treadmill' for the control of obesity -- though it of course would not provide all the additional benefits of exercise. The researchers have already identified two compounds that can accomplish that in human cells.

Contact: B. D. Colen
Harvard University

Public Release: 5-Dec-2014
International Journal of Biomedical Engineering and Technology
Stick out your tongue
The tongue can betray signs of illness, which combined with other symptoms such as a cough, fever, presence of jaundice, headache or bowel habits, can help a physician offer a diagnosis. For people in remote areas who do not have ready access to a physician, a new diagnostic system is reported in the International Journal of Biomedical Engineering and Technology that works to combine the soft inputs of described symptoms with a digital analysis of an image of the patient's tongue.

Contact: Albert Ang
Inderscience Publishers

Public Release: 4-Dec-2014
Nature Communications
UCLA study: To stop spread of HIV, African governments should target hot zones
To stop the spread of HIV in Africa, researchers at UCLA, using a complex mathematical model, have developed a strategy that focuses on targeting 'hot zones,' areas where the risk of HIV infection is much higher than the national average.

Contact: Mark Wheeler
University of California - Los Angeles

Public Release: 4-Dec-2014
Ebola rapid response
The National Science Foundation has awarded the first of a number of rapid response grants to advance fundamental Ebola research. The grants will support researchers seeking to answer important questions about the virus's fundamental nature, how it interacts with other substances, how it spreads, and how communication and perception affect public safety during an epidemic.
National Science Foundation

Contact: Sarah Bates
National Science Foundation

Public Release: 4-Dec-2014
PLOS Pathogens
Blood pressure build-up from white blood cells may cause cerebral malaria death
Intracranial hypertension -- increased blood pressure inside the head -- can predict a child's risk of death from malaria. A study published on Dec. 4 in PLOS Pathogens reports that accumulation of white blood cells impairs the blood flow out of the brain and causes blood pressure increases in mice with experimentally induced cerebral malaria.
Dana Foundation, National Institutes of Health

Contact: Ute Frevert

Public Release: 4-Dec-2014
Friendly bacteria are protective against malaria
In a breakthrough study to be published on the Dec. 4 issue of the prestigious scientific journal Cell, a research team led by Miguel Soares at the Instituto Gulbenkian de Ciencia discovered that specific bacterial components in the human gut microbiota can trigger a natural defense mechanism that is highly protective against malaria transmission.
Bill and Melinda Gates Foundation, Fundano para a Ciencia e a Tecnologia, European Research Council

Contact: Ana Mena
Instituto Gulbenkian de Ciencia

Public Release: 3-Dec-2014
Parasite researcher wins international malaria medal
Melbourne researcher professor Alan Cowman has won the Sornchai Looareesuwan Medal 2014 for his significant contributions to understanding how the malaria parasite causes disease and for his search for potential malaria vaccines.

Contact: Alan Gill
Walter and Eliza Hall Institute

Public Release: 3-Dec-2014
Volunteers can now help scientists seek Ebola cure in their (computer's) spare time
Beginning today, anyone can download a safe and free app that will put their computer or Android-based mobile device to work to form a virtual supercomputer to help The Scripps Research Institute screen millions of chemical compounds to identify new drug leads for treating Ebola. Meanwhile, the devices will remain fully available for normal use by their owners.

Contact: Madeline McCurry-Schmidt
Scripps Research Institute

Public Release: 2-Dec-2014
Novel nanoparticle technology to be used to screen for Ebola virus in saliva
Ceres Nanosciences will work with George Mason University and the United States Army Medical Research Institutes of Infectious Diseases to assess the ability of the Nanotrap technology to develop a more sensitive and safer Ebola virus detection method that uses saliva instead of blood.
Bill & Melinda Gates Foundation

Contact: Michele McDonald
George Mason University

Public Release: 1-Dec-2014
Experts question aspects of certain Ebola guidelines
Various guidelines for caring for patients infected with Ebola virus are being issued from different national and state public health authorities, professional societies, and individual hospitals. Experts are questioning aspects of some of the guidelines that go beyond current CDC recommendations, especially those that call for suspending certain routine lab tests.

Contact: Dawn Peters

Public Release: 29-Nov-2014
Canada funds 11 new global health innovations in La Francophonie member states
Grand Challenges Canada, funded by the Government of Canada, today announced $1.2 million in funding for 11 new global health innovations implemented in member states of La Francophonie. All new projects excel in boldness and creativity and aim to address pressing health challenges, such as malaria, malnutrition and sanitation. They will help to improve maternal, newborn and child health, Canada's top development priority.
Grand Challenges Canada

Contact: Lode Roels
Grand Challenges Canada

Public Release: 27-Nov-2014
Secret of tetanus toxicity offers new way to treat motor neuron disease
The way that tetanus neurotoxin enters nerve cells has been discovered by UCL scientists, who showed that this process can be blocked, offering a potential therapeutic intervention for tetanus. This newly-discovered pathway could be exploited to deliver therapies to the nervous system, opening up a whole new way to treat neurological disorders such as motor neuron disease and peripheral neuropathies.
Medical Research Council, Cancer Research UK

Contact: Siobhan Pipa
University College London

Public Release: 26-Nov-2014
New England Journal of Medicine
NIAID/GSK experimental Ebola vaccine appears safe, prompts immune response
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline, was tested at the NIH Clinical Center in Bethesda, Md.
NIH/National Institute of Allergy and Infectious Disease, GlaxoSmithKline

Contact: Anne A. Oplinger
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 25-Nov-2014
Powdered measles vaccine found safe in early clinical trials
A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published Nov. 28 in the journal Vaccine. The paper is now available online.
National Institutes of Health, Bill and Melinda Gates Foundation

Contact: Robert Sievers
University of Colorado at Boulder

Public Release: 25-Nov-2014
BMC Public Health
International team reveals barriers to public health data-sharing; life-saving solutions
Barriers to the sharing of public health data hamper decision-making efforts on local, national and global levels, and stymie attempts to contain emerging global health threats, an international team led by the University of Pittsburgh Graduate School of Public Health announced today.
Bill & Melinda Gates Foundation, NIH/National Institute of General Medical Sciences

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Public Release: 25-Nov-2014
European Heart Journal
'Utter neglect' of rheumatic heart disease revealed by results from global study
Rheumatic heart disease -- the most common acquired heart disease in children in many countries of the world -- is being neglected and poorly treated, according to new findings from the Global Rheumatic Heart Disease Registry (the REMEDY study), published online in the European Heart Journal.

Contact: Emma Mason
European Society of Cardiology

Showing releases 876-900 out of 1224.

<< < 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 > >>